AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
8 registrations across 4 African markets— 7 active
Markets with EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Emtricitabine and Tenofovir Alafenamide Tablets 200 mg/25 mg ORAL TABLET | 🇷🇼Rwanda | Mylan Laboratories Limited | active | Feb 2031 |
| Descovy 200 mg/25mg Film-Coated Tablet | 🇰🇪Kenya | Gilead Sciences, Inc. | active | Feb 2028 |
| Emtricitabine and Tenofovir alafenamide Tablets… Film-Coated Tablet | 🇰🇪Kenya | Hetero labs limited | active | Dec 2027 |
| Descovy 200mg/10mg Film-Coated Tablet | 🇰🇪Kenya | Gilead Sciences, Inc. | active | Sept 2027 |
| EMTRICITABINE_AND_TENOFOVIR_ALAFENAMIDE 200/25MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| Emtricitabine + Tenofovir alafenamide fumarate Tablets | 🇹🇿Tanzania | Mylan Laboratories Limited | active | — |
| Descovy Tablet, Film-coated | 🇹🇿Tanzania | Gilead Sciences, Inc | active | — |
| Emtricitabine and Tenofovir Alafenamide Film Coated Tablet | 🇹🇿Tanzania | LAURUS LABS LIMITED | active | — |
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE in Africa — Regulatory Overview
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE is registered across 4 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Tanzania, Malawi, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 7 (88%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.